News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
267,448 Results
Type
Article (13956)
Company Profile (101)
Press Release (253391)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (88354)
Career Advice (465)
Deals (15397)
Drug Delivery (67)
Drug Development (36767)
Employer Resources (49)
FDA (6339)
Job Trends (6222)
News (150853)
Policy (14123)
Tag
Academia (441)
Accelerated approval (2)
Adcomms (6)
Allergies (38)
Alliances (23310)
ALS (39)
Alzheimer's disease (396)
Antibody-drug conjugate (ADC) (46)
Approvals (6379)
Artificial intelligence (115)
Autoimmune disease (9)
Automation (5)
Bankruptcy (149)
Best Places to Work (4370)
BIOSECURE Act (9)
Biosimilars (57)
Biotechnology (40)
Bladder cancer (22)
Brain cancer (16)
Breast cancer (84)
Cancer (658)
Cardiovascular disease (74)
Career advice (409)
Career pathing (12)
CAR-T (24)
Cell therapy (92)
Cervical cancer (4)
Clinical research (31127)
Collaboration (369)
Compensation (168)
Complete response letters (17)
COVID-19 (760)
CRISPR (23)
C-suite (136)
Cystic fibrosis (39)
Data (709)
Denatured (15)
Depression (10)
Diabetes (84)
Diagnostics (1330)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (61)
Drug pricing (71)
Drug shortages (12)
Duchenne muscular dystrophy (41)
Earnings (32486)
Editorial (14)
Employer branding (4)
Employer resources (43)
Events (37722)
Executive appointments (415)
FDA (6837)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (226)
Gene editing (41)
Generative AI (9)
Gene therapy (105)
GLP-1 (354)
Government (1308)
Grass and pollen (3)
Guidances (71)
Healthcare (3567)
Huntington's disease (4)
IgA nephropathy (13)
Immunology and inflammation (38)
Indications (14)
Infectious disease (795)
Inflammatory bowel disease (58)
Inflation Reduction Act (6)
Influenza (14)
Intellectual property (50)
Interviews (59)
IPO (5893)
IRA (29)
Job creations (2070)
Job search strategy (373)
Kidney cancer (6)
Labor market (14)
Layoffs (184)
Leadership (4)
Legal (3463)
Liver cancer (19)
Lung cancer (88)
Lymphoma (57)
Machine learning (4)
Management (16)
Manufacturing (176)
MASH (36)
Medical device (1281)
Medtech (1283)
Mergers & acquisitions (9729)
Metabolic disorders (272)
Multiple sclerosis (22)
NASH (14)
Neurodegenerative disease (27)
Neuropsychiatric disorders (8)
Neuroscience (594)
NextGen: Class of 2025 (1588)
Non-profit (597)
Now hiring (8)
Obesity (153)
Opinion (120)
Ovarian cancer (22)
Pain (58)
Pancreatic cancer (17)
Parkinson's disease (48)
Partnered (7)
Patents (131)
Patient recruitment (30)
Peanut (10)
People (29155)
Pharmaceutical (64)
Pharmacy benefit managers (13)
Phase I (8080)
Phase II (13166)
Phase III (11809)
Pipeline (572)
Policy (75)
Postmarket research (1437)
Preclinical (3245)
Press Release (25)
Prostate cancer (49)
Psychedelics (8)
Radiopharmaceuticals (121)
Rare diseases (175)
Real estate (2647)
Recruiting (17)
Regulatory (10206)
Reports (14)
Research institute (568)
Resumes & cover letters (55)
Rett syndrome (1)
RNA editing (2)
RSV (8)
Schizophrenia (39)
Series A (39)
Series B (16)
Service/supplier (3)
Sickle cell disease (32)
Special edition (6)
Spinal muscular atrophy (78)
Sponsored (6)
Startups (1638)
State (2)
Stomach cancer (3)
Supply chain (32)
Tariffs (39)
The Weekly (30)
Vaccines (161)
Venture capitalists (14)
Weight loss (101)
Women's health (8)
Worklife (4)
Date
Today (74)
Last 7 days (322)
Last 30 days (1157)
Last 365 days (11650)
2025 (4430)
2024 (12504)
2023 (14257)
2022 (19572)
2021 (20084)
2020 (19056)
2019 (14893)
2018 (11719)
2017 (13897)
2016 (13135)
2015 (15482)
2014 (12426)
2013 (10607)
2012 (11412)
2011 (11955)
2010 (10936)
Location
Africa (315)
Alabama (13)
Alaska (1)
Arizona (61)
Arkansas (3)
Asia (20201)
Australia (2624)
California (1886)
Canada (967)
China (257)
Colorado (73)
Connecticut (74)
Delaware (64)
Europe (39734)
Florida (363)
Georgia (40)
Idaho (9)
Illinois (209)
India (16)
Indiana (142)
Iowa (1)
Japan (102)
Kansas (60)
Kentucky (13)
Louisiana (2)
Maine (2)
Maryland (280)
Massachusetts (1631)
Michigan (31)
Minnesota (101)
Missouri (23)
Montana (8)
Nebraska (6)
Nevada (9)
New Hampshire (6)
New Jersey (823)
New Mexico (7)
New York (555)
North Carolina (410)
North Dakota (2)
Northern California (783)
Ohio (51)
Oklahoma (4)
Oregon (16)
Pennsylvania (479)
Puerto Rico (8)
Rhode Island (10)
South America (507)
South Carolina (3)
Southern California (795)
Tennessee (36)
Texas (253)
United States (7843)
Utah (36)
Virginia (84)
Washington D.C. (32)
Washington State (128)
Wisconsin (21)
267,448 Results for "schering plough pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Testimony: Elizabeth Holmes Mislead Investors with Use of Schering-Plough Logo
Immunology expert Constance Cullen of Schering-Plough Corp. revealed that Theranos inappropriately attached Schering-Plough’s logo to data issued to potential investors.
November 3, 2021
·
3 min read
·
Alex Keown
Business
RenovoRx Appoints Former Chief Medical Officer of Schering-Plough, Robert J. Spiegel, MD, FACP, to Board of Directors
RenovoRx, Inc announced today that Robert J. Spiegel, MD, has been appointed to the Company’s Board of Directors, effective April 25, 2023.
April 27, 2023
·
4 min read
BioMidwest
Scitech and the Plough Center Announce Manufacturing Agreement
SciTech Development is pleased to announce that it has signed a $600K manufacturing agreement with The Plough Center for Sterile Drug Delivery Systems.
October 20, 2022
·
2 min read
Press Releases
Yaqrit strengthens funding and regulatory capability ahead of clinical trials with board and senior management team appointments
May 14, 2025
·
3 min read
Business
Entheon Biomedical Announces Nancy Maher, Special Advisor of Data Science and Regulatory Affairs
Ms. Maher has served as an executive and consultant for major pharmaceutical and information technology companies, including IBM, Gilead, Schering-Plough, Merck, Allergan, and Teva Pharmaceuticals.
March 3, 2021
·
5 min read
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
Press Releases
Catalent Announces New Board Appointments
February 20, 2025
·
4 min read
Press Releases
EyePoint Pharmaceuticals Appoints Esteemed Industry Leader Fred Hassan to Board of Directors
September 5, 2024
·
7 min read
Mergers & acquisitions
Taiho Pharmaceutical Buys ADC Partner Araris for up to $1.1B Total
Japan-based Taiho Pharmaceutical has worked with Araris Biotech since 2023 developing antibody-drug conjugates for the oncology space.
March 17, 2025
·
2 min read
·
Dan Samorodnitsky
Business
Respira Technologies, Inc. Announces Partnership With The Plough Center For Sterile Drug Delivery At The University Of Tennessee Health Science Center
Respira Technologies, Inc. announced , its partnership with the Plough Center for Sterile Drug Delivery at the University of Tennessee Health Science Center to execute aseptic drug product handling and cartridge filling to support the companies planned IND submission to the FDA and to prepare for human clinical studies.
March 22, 2022
·
3 min read
1 of 26,745
Next
